多重檢測免疫檢測全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計多重檢測免疫檢測的市場規模將從 2025 年的 23.6 億美元成長到 2034 年的 59.2 億美元，並預計從 2026 年到 2034 年將以 10.76% 的複合年成長率成長。

對高效、高通量診斷解決方案日益成長的需求正在推動全球多重檢測免疫檢測市場的快速擴張。這些檢測法能夠從單一檢體同時檢測多種生物標記物，在疾病診斷、藥物研發和研究應用中展現出不可估量的價值。對癌症和感染疾病等複雜疾病早期準確診斷需求的不斷成長，也進一步推動了市場成長。

關鍵成長要素包括生物技術的進步、研發投入的增加以及個人化醫療的日益普及。與傳統的單項分析檢測相比，多重免疫檢測具有更高的成本效益和時間效率，因此在臨床和檢查室應用中極具吸引力。此外，慢性病盛行率的上升以及對綜合診斷解決方案日益成長的需求也進一步推動了市場需求。

未來，隨著自動化、人工智慧和先進數據分析技術的融合，市場預計將顯著成長。高靈敏度和高特異性檢測平台的開發將提高診斷準確性。精準醫療和生物標記發現領域應用的拓展將創造新的機遇，使多重免疫檢測成為現代醫學診斷的關鍵技術。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球多重檢測免疫檢測市場：依產品類型分類

• 市場分析、洞察與預測
• 試劑和試劑盒
• 裝置
• 軟體服務

第5章：全球多重檢測免疫檢測市場：依技術分類

• 市場分析、洞察與預測
• 基於蛋白質的多重檢測免疫檢測
• 基於核酸的多重免疫檢測
• 其他

第6章：全球多重檢測免疫檢測市場：依應用分類

• 市場分析、洞察與預測
• 疾病診斷
• 藥物研發
• 生物標記發現
• 其他

第7章 全球多重檢測免疫檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 診斷檢查室
• 其他

第8章：全球多重檢測免疫檢測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Merck KGaA
  • Becton
  • Dickinson And Company
  • Illumina Inc
  • Agilent Technologies Inc
  • PerkinElmer Inc
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • Promega Corporation
  • Abcam Plc
  • Luminex Corporation
  • Bio-Techne Corporation

The Multiplex Detection Immunoassay Market size is expected to reach USD 5.92 Billion in 2034 from USD 2.36 Billion (2025) growing at a CAGR of 10.76% during 2026-2034.

The global multiplex detection immunoassay market is expanding rapidly due to the increasing need for efficient and high-throughput diagnostic solutions. These assays allow simultaneous detection of multiple biomarkers in a single sample, making them highly valuable in disease diagnosis, drug development, and research applications. Growing demand for early and accurate diagnosis of complex diseases such as cancer and infectious disorders is driving market growth.

Major growth drivers include advancements in biotechnology, increasing investments in research and development, and the rising adoption of personalized medicine. Multiplex immunoassays offer cost and time efficiency compared to traditional single-analyte tests, making them attractive for clinical and laboratory use. Additionally, the growing prevalence of chronic diseases and the need for comprehensive diagnostic solutions are further boosting demand.

In the future, the market is expected to grow significantly with the integration of automation, AI, and advanced data analytics. The development of highly sensitive and specific assay platforms will enhance diagnostic accuracy. Expanding applications in precision medicine and biomarker discovery will create new opportunities, positioning multiplex immunoassays as a key technology in modern healthcare diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Reagents & Kits
• Instruments
• Software & Services

By Technology

• Protein-based Multiplex Detection Immunoassay
• Nucleic Acid-based Multiplex Detection Immunoassay
• Others

By Application

• Disease Diagnostics
• Drug Development
• Biomarker Discovery
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson and Company, Illumina Inc, Agilent Technologies Inc, PerkinElmer Inc, BioRad Laboratories Inc, QIAGEN NV, Promega Corporation, Abcam plc, Luminex Corporation, BioTechne Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Protein-based Multiplex Detection Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Nucleic Acid-based Multiplex Detection Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Disease Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MULTIPLEX DETECTION IMMUNOASSAY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Danaher Corporation
  • 10.2.3 Roche Diagnostics
  • 10.2.4 Siemens Healthineers AG
  • 10.2.5 Merck KGaA
  • 10.2.6 Becton
  • 10.2.7 Dickinson And Company
  • 10.2.8 Illumina Inc
  • 10.2.9 Agilent Technologies Inc
  • 10.2.10 PerkinElmer Inc
  • 10.2.11 Bio-Rad Laboratories Inc
  • 10.2.12 QIAGEN N.V
  • 10.2.13 Promega Corporation
  • 10.2.14 Abcam Plc
  • 10.2.15 Luminex Corporation
  • 10.2.16 Bio-Techne Corporation